April 3, 2018
A partnership between Louisville, Kentucky city leaders, a non-profit, and digital respiratory health company Propeller Health has led to clear improvements in local asthmatic residents’ inhaler use and symptoms, according to a study recently published in Health Affairs.
Furthermore, data collected and made available through the digital respiratory health company’s crowdsourced platform offered...
April 2, 2018
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.
Adherium — which is headquartered in San Mateo, California, but holds currently offices in Melbourne, Australia; Auckland, New Zealand; and Amstelveen, The Netherlands...
January 24, 2018
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.
“We’ve had a great relationship over the last couple of years with AstraZeneca, we’ve launched in a couple dozen countries now...
January 10, 2018
Preventative telemedicine could play a key role in helping school-aged children with asthma manage their condition. A recent study published in JAMA Pediatrics, reported that kids who used telemedicine and in-school care for their asthma had fewer visits to the ER than children who used enhanced usual care.
“The telemedicine model is one form of connected care that enhances access to medical...
December 19, 2017
Brisbane, Australia-based ResApp is planning to re-do its big US trial soon, but in the meantime the smartphone respiratory diagnosis company is continuing to collect data in its native country.
The company released data yesterday from a clinical study of more than 1,300 adult patients at Joondalup Health Campus in Perth and Wesley Hospital in Brisbane. While the company’s previous studies have...
November 16, 2017
Express Scripts members will now have access to Propeller’s FDA-cleared digital platform for respiratory health. Today, the two companies announced a partnership which they claim is the largest respiratory digital health deployment with a pharmacy benefit manager yet.
The Propeller system allows a patients to attach a sensor to their inhaler, which is synced to an app on the users smart phone....
November 2, 2017
North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with a mobile app can be used to verify dose delivery in real-time.
“What we’ve done is created the first electronically breath-actuated inhaler,” James Bauler, VP of business development at Pneuma...
October 10, 2017
Madison, Wisconsin-based Propeller Health is taking its asthma alert messaging to the masses, as the longtime digital respiratory health company announced today that it is releasing Air, a free and open API that provides information on local asthma conditions.
Air makes asthma forecasts by pulling geographic data on humidity, wind direction, temperature, and other pollutants collected by the...
September 1, 2017
Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, dubbed the SmartTouch for Symbicort.
The SmartTouch is a device that grafts onto a patient’s inhaler to monitor and encourage medication adherence as...
August 24, 2017
Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for, and undertake, commercial activities using the Propeller clip-on sensor and software platform for use with GSK’s ELLIPTA Inhaler.
Ongoing research and development efforts will continue, with...